Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04430192 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy

Study acronym: LuTectomy
StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Dec 30, 2023 to Aug 30, 2025v5
  2. Primary completion date changed from estimate of Aug 7, 2022 to Dec 22, 2022
    • Study completion date: Jun 30, 2023 to Dec 30, 2023
    v4
  3. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Jun 30, 2022 to Aug 7, 2022
    • Start date changed from estimate of Jun 9, 2020 to Aug 6, 2020
    • Secondary endpoints: details revised at 3 of 8 entries
    • Site details revised
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial will evaluate the dosimetry, efficacy and toxicity of Lu-PSMA in men with high PSMA-expressing high-risk localized or locoregional advanced prostate cancer (HRCaP) undergoing radical prostatectomy (RP) and pelvic lymph node dissection (PLND)
Trial Details
NCT Number NCT04430192
Lead Sponsor Peter MacCallum Cancer Centre, Australia
Collaborators: Movember Foundation, Medical Research Future Fund, Endocyte, E.J. Whitten Foundation Prostate Cancer Research Centre
Conditions
(from sponsor)		 Prostatic Neoplasms
Related terms Prostatic Neoplasms
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov